What is Idexx Laboratories Inc's Market Cap?

Idexx Laboratories Inc's Market Cap is $44.1B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Enterprise Value?

Idexx Laboratories Inc's Enterprise Value is $44.4B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Trailing P/E?

Idexx Laboratories Inc's Trailing P/E is 38.7×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Price / Sales?

Idexx Laboratories Inc's Price / Sales is 9.7×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's EV / Revenue?

Idexx Laboratories Inc's EV / Revenue is 9.8×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's EV / EBITDA?

Idexx Laboratories Inc's EV / EBITDA is 27.5×, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Revenue (TTM)?

Idexx Laboratories Inc's Revenue (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Net Income (TTM)?

Idexx Laboratories Inc's Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's EBITDA?

Idexx Laboratories Inc's EBITDA is $1.6B, based on as-reported figures from SEC (XBRL) filings.

What is Idexx Laboratories Inc's Diluted EPS (TTM)?

Idexx Laboratories Inc's Diluted EPS (TTM) is 14.47, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Idexx Laboratories Inc

XNAS · usd

SIC 2835 · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

FIGI BBG001S5S4Y9

560.38▼ 6.38 (-1.13%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 566.76
Day's Range: 558.29 – 569.56
52-Week Range: 500.61 – 769.98
Volume: 397.9K
Avg Volume: 506.4K

Share Statistics

Shares Outstanding
Employees: 11.0K
Exchange: XNAS
Listed: 1991-06-21

Share count as of July 31, 2026

Idexx Laboratories Inc (IDXX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Idexx Laboratories Inc (IDXX)

What is Idexx Laboratories Inc's Market Cap?: Idexx Laboratories Inc's Market Cap is $44.1B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Enterprise Value?: Idexx Laboratories Inc's Enterprise Value is $44.4B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Trailing P/E?: Idexx Laboratories Inc's Trailing P/E is 38.7×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Price / Sales?: Idexx Laboratories Inc's Price / Sales is 9.7×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's EV / Revenue?: Idexx Laboratories Inc's EV / Revenue is 9.8×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's EV / EBITDA?: Idexx Laboratories Inc's EV / EBITDA is 27.5×, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Revenue (TTM)?: Idexx Laboratories Inc's Revenue (TTM) is $4.6B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Net Income (TTM)?: Idexx Laboratories Inc's Net Income (TTM) is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's EBITDA?: Idexx Laboratories Inc's EBITDA is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Idexx Laboratories Inc's Diluted EPS (TTM)?: Idexx Laboratories Inc's Diluted EPS (TTM) is 14.47, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · IDXXAs-filed SEC (XBRL) data